gabapentin has been researched along with Cardiovascular Diseases in 6 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with diabetic neuropathy who were prescribed gabapentin and pregabalin, there is an increased risk for heart failure, myocardial infarction, peripheral vascular disease, stroke, deep venous thrombosis, and pulmonary embolism with long-term use." | 4.12 | Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. ( Blankfield, RP; Davis, PB; Kaebler, DC; Pan, Y; Xu, R, 2022) |
| "As clonidine has been associated with cardiovascular adverse effects, it should be administered only in cases where blood pressure regulation is mandatory." | 2.61 | Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk? ( Ampatzi, C; Goulis, DG; Mareti, E; Paschou, SA; Voziki, E, 2019) |
| "Neuropathic pain was the most common indication (33." | 1.48 | Patterns of pain medication use in older individuals with cardiovascular disease. ( Dimassi, H; Kabbara, WK; Sheikh-Taha, M, 2018) |
| " GBP has a favorable adverse effect profile in therapeutic dosing with the most common reported effects being dizziness, fatigue, drowsiness, weight gain, and peripheral edema." | 1.42 | An acute gabapentin fatality: a case report with postmortem concentrations. ( Cantrell, FL; Gary, RD; McIntyre, IM; Mena, O, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, Y | 1 |
| Davis, PB | 1 |
| Kaebler, DC | 1 |
| Blankfield, RP | 1 |
| Xu, R | 1 |
| Várkonyi, T | 1 |
| Körei, A | 1 |
| Putz, Z | 1 |
| Martos, T | 1 |
| Keresztes, K | 1 |
| Lengyel, C | 1 |
| Nyiraty, S | 1 |
| Stirban, A | 1 |
| Jermendy, G | 1 |
| Kempler, P | 1 |
| Cobin, RH | 1 |
| Goodman, NF | 1 |
| Kabbara, WK | 1 |
| Dimassi, H | 1 |
| Sheikh-Taha, M | 1 |
| Mareti, E | 1 |
| Ampatzi, C | 1 |
| Paschou, SA | 1 |
| Voziki, E | 1 |
| Goulis, DG | 1 |
| Cantrell, FL | 1 |
| Mena, O | 1 |
| Gary, RD | 1 |
| McIntyre, IM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Connective Tissue Manipulation on Menopausal Symptoms[NCT05293860] | 58 participants (Anticipated) | Interventional | 2022-04-04 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for gabapentin and Cardiovascular Diseases
| Article | Year |
|---|---|
Advances in the management of diabetic neuropathy.
Topics: Adjuvants, Immunologic; Amines; Anticonvulsants; Antidepressive Agents; Antioxidants; Cardiovascular | 2017 |
Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
Topics: Cardiovascular Diseases; Clonidine; Female; Gabapentin; Humans; Menopause; Phytoestrogens; Pregabali | 2019 |
4 other studies available for gabapentin and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.
Topics: Amines; Analgesics; Cardiovascular Diseases; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gab | 2022 |
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Amines; Breast Neoplasms; Cardiovascular Dise | 2017 |
Patterns of pain medication use in older individuals with cardiovascular disease.
Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, No | 2018 |
An acute gabapentin fatality: a case report with postmortem concentrations.
Topics: Amines; Analgesics; Cardiovascular Diseases; Chromatography, Liquid; Cyclohexanecarboxylic Acids; Fe | 2015 |